Compliance is built at the Design Table.
Not Fixed During the Audits.
Risk-Based GxP Strategy for Pharma, Biotech & Medical Device Companies
Making GxP Compliance Smarter, Leaner, and Inspection-Ready.
What I Do?
I help pharma teams solve validation and compliance challenges before they become inspection findings.
Validation
- Process
- Cleaning
- Equipment
- Utilities
- Computerized Systems
Quality Systems
- Data Integrity by Design
- Structuring Risk-Based SOPs
- QMS Gap Assessment & Remediation
Audit Readiness
- Mock inspections
- Auditor dossier setup
- Warning letter proof controls
Facility and Process Risk Review
- Weak link detection
- Deviation and CAPA acceleration
- Right first time batch execution
Regulatory Clarity
- Turn gray zones into clear steps
- Right documentation that passes deep scrutiny
- Alignment with Global Regulations like: US, EU, MHRA.
Why Teams Call Me:
- Risk first thinking that finds what others miss
- Real world validation expertise that avoids rework
- Compliance that supports growth instead of slowing it
- I clean messy problems with science backed logic
I believe good companies deserve clean audits.
Results you can Measure:
- Faster batch release
- Confident inspections
- Audit proof validation lifecycle
- Better focus on real quality
If you read my work earlier, thank you. Your time and feedback shaped every post.
Full library and new articles:
For enquiries:
Saket Yeotikar
Chemical Engineer | Compliance Strategist | Risk-Based GxP SME
Based in India – Working Globally.